ArticleInternational journal of clinical oncology2026

Prophylactic intravenous dexamethasone is associated with reduced cutaneous toxicity during first-line enfortumab vedotin plus pembrolizumab for locally advanced or metastatic urothelial carcinoma: a multicenter prospective cohort study.

Rikiya Taoka et al.PubMed ↗Publisher ↗

No numbers read from the abstract.